Before You Sign the MOU: Due Diligence for International Research Partnerships

International collaboration is not a vulnerability—it is the engine of modern science. The most important breakthroughs of the last generation came from symbiotic joint ventures, shared instrumentation, and the free movement of global talent. Any research security approach that treats every foreign partnership as a threat will quietly strangle the very thing it claims to protect.

And yet the memorandum of understanding remains one of the most under-examined documents in the research enterprise. Institutions will spend months negotiating indirect cost rates and publication rights, then sign a partnership agreement with a foreign entity whose ownership structure, government affiliations, and downstream relationships were never independently checked. The risk is not the collaboration itself—it is entering it blind.

The consequences of skipping that step show up later and cost more. Undisclosed ties to entities of concern can jeopardize current federal funding, trigger enforcement scrutiny, and—in critical technology areas—expose an institution to economic espionage and the loss of intellectual property that took decades and millions of research dollars to develop. Across the field, comprehensive programs have remediated more than 4,000 insider risks and protected 20 distinct critical technology categories; the partnerships that went wrong almost always shared one feature in common: no one looked closely before signing.

Grant Hopper closes that gap. As the first AI-enabled due diligence tool purpose-built to assess visiting scholars, prospective researchers, and research grant applicants for foreign influence risk, it lets you evaluate a potential partner efficiently—before the MOU is signed, not after the problem surfaces. Built for academic institutions, government agencies, and corporate R&D teams alike, it turns due diligence from a months-long manual slog into a repeatable step in your partnership workflow.

The goal is not to say “no” to international research. It is to say “yes” with your eyes open. A few minutes of structured due diligence before signing is the cheapest insurance your research enterprise will ever buy.